Advantage of a two-dose Versus one-dose varicella vaccine in healthy non-immune teenagers and young adults

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 3, 2004, Pages 697-701

  Kosuwon, P ^a   Sutra, S ^a   Kosalaraksa, P ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GEOMETRY; HUMAN; IMMUNOGENICITY; MALE; NORMAL HUMAN; SEROCONVERSION; TITRIMETRY; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS STRAIN;

EID: 8444243382     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ACIP, Prevention of varicella updated recommendations of the Advisory Committee on Immunization Practices. MMWR 1999; 48 (RR06): 1-5.
2. Bernstein HH, Rothstein EP, Watson BM, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics 1993; 92: 833-7.
3. Burgess MA, Cossart YE, Wilkins TD, Botham S, Fearns G, Chitour K. Varicella vaccination of health-care workers. Vaccine 1999; 17: 765-9.
4. Centers for Disease Control and Prevention. Prevention of varicella. MMWR 1996; 45 (RR-11): 1-25.
5. Clemens SA, Azvedo T, Fonseca JC, Cavalcante Silva A, de Silveira TR, Clemens R. Seroepidemiology of varicella in Brazil - results of a prospective, cross-sectional study. J Pediatr (Rio J) 1999; 75: 433-41.
6. Clements DA. Varicella vaccination in children. Biodrugs 2000; 14: 49-60.
7. Committee on Infectious Diseases, American Academy of Pediatrics. Varicella vaccine update. Pediatrics 2000; 105: 136-41.
8. Diaz-Mitoma F, Halperin SA, Scheifele D. Reactogenicity to a live attenuated varicella vaccine in Canadian children. Can J Infect Dis 2000; 11: 97-102.
9. Fleisher G, Henry W, McSorley M, Arbeter A, Plotkin S. Life-threatening complications of varicella. Am J Dis Child 1981; 135: 896-9.
10. Gershon AA. The impact of varicella vaccine: present and future. Herpes 1998; 5: 72-4.
11. Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. Theoretical epidemiologic and mobidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 1994a; 140: 81-104.
12. Halloran ME, Watelet L, Struchiner CJ. Epidemiologic effects of vaccines with complex direct effects in an age-structured population. Math Biosci 1994b; 121: 193-225.
13. Halloran ME. Epidemiologic effects of varicella vaccination. Infect Dis Clin North Am 1996; 10: 631-55.
14. Krause PR, Klinman DM. Efficacy, immunogenicity and use of live attenuated chickenpox vaccine. J Pediatr 1995; 127: 518-25.
15. Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991; 9: 643-7.
16. Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 1998; 3: 886-90.
17. Lim YJ, Chew FT, Tan AYS, Lee BW. Risk factors for breakthrough varicella in healthy children. Arch Dis Child 1998; 79: 478-80.
18. Lolekha S, Tanthiphabha W, Sornchai P, et al. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg 2001; 64: 131-6.
19. Ozaki T, Nishimura N, Kajita Y. Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic. Vaccine 2000; 18: 2375-80.
20. Plotkin SA. Varicella vaccine. Pediatrics 1996; 97: 251-3.
21. Rentier B. Varicella vaccination: building on US experience to promote European recommendations [Abstract]. Vaccination in Progress, Progress in Vaccination, Session 1. October 2000.
22. Rusthoven JJ. The risk of varicella-zoster infections in different patient populations: a critical review. Transfu Med Rev 1994; 8: 96-116.
23. th International Congress on Infectious Diseases. April 2000.
24. nd World Congress of Pediatric Infectious Diseases, November 1999: 34.
25. White CJ, Kuter BJ, Ngai A, et al. Modified cases of chicken pox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J 1992; 11: 19-23.
26. White CJ. Varicella zoster virus vaccine. Clin Infect Dis 1997; 24: 753-63.
27. WHO. The WHO Position Paper on Varicella Vaccines, 2001. [last visited 12-06-03]. Available from: URL: http://www.who.int/vaccines-diseases/diseases/ PP_Varicella.htm
28. Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine. J Am Med Assoc 2000; 284: 1271-9.